Evidence map›Paper›PMID 30228889›Full record

ArticleUnited European gastroenterology journal2018

Endoscopic full-thickness resection of duodenal lesions-a retrospective analysis of 20 FTRD cases.

Markus Bauder, Arthur Schmidt, Karel Caca

Abstract read
In one paragraph

Article in United European gastroenterology journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Endoscopic Full Thickness Resection Device (FTRDDiagnostics (Basel, Switzerland) · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Endoscopic full-thickness resection of gastric ulceration with persistent low-grade dysplasia using full-thickness resection device.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2022
    Article
  15. Article
  16. Full-thickness resection: troubleshooting, tips, and tricks for success in the colorectum.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2022
    Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Markus BauderDepartment of Gastroenterology and Oncology, Klinikum Ludwigsburg, Ludwigsburg, Germany.
Arthur SchmidtDepartment of Gastroenterology, Medical Center, University of Freiburg, Freiburg im Breisgau, Baden-Württemberg, Germany.
Karel CacaDepartment of Gastroenterology and Oncology, Klinikum Ludwigsburg, Ludwigsburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndoscopic resections in the duodenum harbor a significant risk of complications. The full-thickness resection device (FTRD) has shown favorable results concerning efficacy and safety in the resection of colorectal lesions. Data of its use in the duodenum are limited to a single, small case series (

methodsData of all consecutive patients scheduled for endoscopic full-thickness resection (EFTR) of duodenal lesions by FTRD in our institution were collected and analyzed retrospectively. Primary endpoint was technical success.

resultsBetween March 2014 and June 2017 EFTR of a duodenal lesion was planned in a total of 20 patients. Overall technical success was 17/20 (85.0%). Indication for EFTR was: adenomas (

conclusionThis study confirmed the feasibility of duodenal EFTR and indicates good efficacy and safety. Larger studies are needed to further investigate this novel technique.

Indexed as

duodenal adenomaduodenumEndoscopic full-thickness resectionFTRDsubepithelial tumor

Identifiers

PMID30228889
PMCPMC6137579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.